Ceftaroline fosamil is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults (see Precautions and Pharmacology: Pharmacodynamics under Actions): Complicated skin and soft tissue infections (cSSTI), Community-acquired pneumonia (CAP).
Consideration should be given to official guidance on the appropriate use of antibacterial agents.